K562-eGFP-Puro

K562-eGFP-Puro is a clonal population of the chronic myelogenous leukemia (CML) cell line K562 that has been engineered to stably express enhanced green fluorescent protein.

  • Species: Human
  • Cell Type: Chronic Myelogenous Leukemia
  • Endogenous Target Antigen: GPRC5D (low)
  • Transgene: Enhanced green fluorescent protein (eGFP)
  • Selection Gene: Puromycin
Description

The K562-eGFP-Puro cell line was generated by transducing parental K562 cells with lentiviral vector encoding enhanced green fluorescent protein and the puromycin resistance gene (LV-SFFV-eGFP-PGK-Puro (LV031)). Transduced cells were subsequently selected using puromycin followed by clonal selection using a methylcellulose based semi-solid medium.

This cell line has been tested for mycoplasma and no mycoplasma has been detected. The parental K562 cell line was authenticated by short tandem repeat (STR) profiling.

Characterization

Morphology


Low and high density cell photos (200x).

eGFP Expression


K562-eGFP-Puro (green) or parental K562 (grey) cells were fixed with paraformaldehyde and analyzed by flow cytometry.

Growth Conditions

Complete Growth Medium: Iscove’s Modified Dulbecco’s Medium (IMDM) supplemented with 15% fetal bovine serum (FBS) and 1X Penicillin/Streptomycin.

The addition of 6 µg/mL puromycin to the complete growth medium is recommended if maintaining the cells in culture for more than two weeks.

Grow cells in the indicated medium, subculturing as needed to maintain a density between 4 x 105 and 2 x 106 cells/mL. Passage cells by dilution in fresh medium with occasional complete media changes.

Usage Information

These cells are suitable for in vitro and in vivo experimentation.

eGFP is not recommended for whole animal in-­live imaging. Rather, samples can be collected post mortem for analysis by conventional fluorescence microscopy or flow cytometry.

K562 cells form subcutaneous tumors and systemic disseminated tumors at multiple sites (liver, spleen, bone marrow) upon implantation into immunocompromised mice.

These cells can be amplified to generate additional frozen stocks and cryopreservation of low passage stocks in a designated cryopreservation medium is recommended.

These cells were generated by transduction with a self-inactivating Risk Group 3 (RG3) lentiviral vector. All work should be performed under appropriate biosafety conditions per institutional guidelines.

Datasheet/COA

    Read Our Publications

    Choosing an Appropriate Tumor Model

    Lentiviral Vector Retargeting Technologies

    Video poster featuring scientific visualization of biotech research or cellular imagery

    Welcome To Imanis

    Related Products

    Cell & Virus Products Built for Breakthroughs

    Don’t see what you need in our catalog? Our scientific team engineers cell lines, viral vectors, and assays and provides the characterization data you need to move forward with confidence.